Two terms from tonight’s brief, each with a plain-English explanation and the drug-development idea it most resembles.
The day a month’s stock options run out, usually the third Friday. Traders who hedged those options buy or sell shares as they unwind, which can make prices swing more than the news alone would.
Biotech bridgeA readout date: positions built around it get closed out, whatever the data say.
Seen in the briefDriver 4 in 04S.
How much a fund has bet in total, long and short added together, compared with its own money. A fund at 208% gross leverage has positions worth about twice its capital. When it falls fast, funds are selling and buying back at the same time.
Biotech bridgeA portfolio company running many programs on one raise: cutting programs fast frees cash but stops work.
Seen in the briefGoldman’s prime brokerage data, driver 4 in 04S.